Efficacy and safety of methylcobalamin, alpha lipoic acid and pregabalin combination versus pregabalin monotherapy in improving pain and nerve conduction velocity in type 2 diabetes associated impaired peripheral neuropathic condition. [MAINTAIN]: Results of a pilot study

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Vasudevan, D., Naik, Manoj M., Mukaddam, Qayum I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251034/
https://www.ncbi.nlm.nih.gov/pubmed/25506182
http://dx.doi.org/10.4103/0972-2327.144048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251034/
https://www.ncbi.nlm.nih.gov/pubmed/25506182
http://dx.doi.org/10.4103/0972-2327.144048

Ejemplares similares